<VariationArchive RecordType="classified" VariationID="975851" VariationName="NM_001127898.4(CLCN5):c.1329dup (p.Asn444fs)" VariationType="Duplication" Accession="VCV000975851" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-07-29" DateCreated="2020-08-16" MostRecentSubmission="2020-08-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="963390" VariationID="975851">
      <GeneList>
        <Gene Symbol="CLCN5" FullName="chloride voltage-gated channel 5" GeneID="1184" HGNC_ID="HGNC:2023" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="49922596" stop="50099230" display_start="49922596" display_stop="50099230" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="49687224" stop="49863891" display_start="49687224" display_stop="49863891" Strand="+" />
          </Location>
          <OMIM>300008</OMIM>
          <Haploinsufficiency last_evaluated="2012-10-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CLCN5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-10-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CLCN5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001127898.4(CLCN5):c.1329dup (p.Asn444fs)</Name>
      <CanonicalSPDI>NC_000023.11:50086638:CCCC:CCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="50086638" stop="50086639" display_start="50086638" display_stop="50086639" variantLength="1" positionVCF="50086638" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="49851295" stop="49851296" display_start="49851295" display_stop="49851296" variantLength="1" positionVCF="49851295" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>N374fs</ProteinChange>
      <ProteinChange>N394fs</ProteinChange>
      <ProteinChange>N444fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.49851299dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.49851299dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.50086642dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.50086642dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007159.3" sequenceAccession="NG_007159" sequenceVersion="3" change="g.169027dup">
            <Expression>NG_007159.3:g.169027dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000084.5" sequenceAccession="NM_000084" sequenceVersion="5" change="c.1119dup">
            <Expression>NM_000084.5:c.1119dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000075.1" sequenceAccession="NP_000075" sequenceVersion="1" change="p.Asn374fs">
            <Expression>NP_000075.1:p.Asn374fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127898.4" sequenceAccession="NM_001127898" sequenceVersion="4" change="c.1329dup" MANESelect="true">
            <Expression>NM_001127898.4:c.1329dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121370.1" sequenceAccession="NP_001121370" sequenceVersion="1" change="p.Asn444fs">
            <Expression>NP_001121370.1:p.Asn444fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127899.4" sequenceAccession="NM_001127899" sequenceVersion="4" change="c.1329dup">
            <Expression>NM_001127899.4:c.1329dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121371.1" sequenceAccession="NP_001121371" sequenceVersion="1" change="p.Asn444fs">
            <Expression>NP_001121371.1:p.Asn444fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282163.2" sequenceAccession="NM_001282163" sequenceVersion="2" change="c.1179dup">
            <Expression>NM_001282163.2:c.1179dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269092.1" sequenceAccession="NP_001269092" sequenceVersion="1" change="p.Asn394fs">
            <Expression>NP_001269092.1:p.Asn394fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1933898062" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001127898.4(CLCN5):c.1329dup (p.Asn444fs) AND Dent disease type 1" Accession="RCV001252964" Version="2">
        <ClassifiedConditionList TraitSetID="3210">
          <ClassifiedCondition DB="MedGen" ID="C1848336">Dent disease type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-10-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-08-16" MostRecentSubmission="2020-08-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3210" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="968" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nephrolithiasis, hypercalciuric</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dent disease type 1</ElementValue>
                <XRef ID="MONDO:0010225" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephrolithiasis, hypercalciuria X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Urolithiasis, hypercalciuric X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephrolithiasis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEPHROLITHIASIS, HYPERCALCIURIC, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="300009" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPHL2</ElementValue>
                <XRef Type="MIM" ID="300009" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dent disease, an X-linked disorder of proximal renal tubular dysfunction, is characterized by low molecular weight (LMW) proteinuria, hypercalciuria, and at least one additional finding including nephrocalcinosis, nephrolithiasis, hematuria, hypophosphatemia, chronic kidney disease (CKD), and evidence of X-linked inheritance. Males younger than age ten years may manifest only LMW proteinuria and/or hypercalciuria, which are usually asymptomatic. Thirty to 80% of affected males develop end-stage renal disease (ESRD) between ages 30 and 50 years; in some instances ESRD does not develop until the sixth decade of life or later. The disease may also be accompanied by rickets or osteomalacia, growth restriction, and short stature. Disease severity can vary within the same family. Males with Dent disease 2 (caused by pathogenic variants in OCRL) may also have mild intellectual disability, cataracts, and/or elevated muscle enzymes. Due to random X-chromosome inactivation, some female carriers may manifest hypercalciuria and, rarely, renal calculi and moderate LMW proteinuria. Females rarely develop CKD.</Attribute>
                <XRef ID="NBK99494" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22876375</ID>
                <ID Source="BookShelf">NBK99494</ID>
              </Citation>
              <XRef ID="1652" DB="Orphanet" />
              <XRef ID="93622" DB="Orphanet" />
              <XRef ID="C1848336" DB="MedGen" />
              <XRef ID="MONDO:0010225" DB="MONDO" />
              <XRef Type="MIM" ID="300009" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2819607" SubmissionDate="2020-08-30" DateLastUpdated="2020-08-16" DateCreated="2020-08-16">
        <ClinVarSubmissionID localKey="NM_000084.4:c.1119dupC|OMIM:300009" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001427205" DateUpdated="2020-08-16" DateCreated="2020-08-16" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A hemizygous duplication variant, NM_000084.4(CLCN5):c.1119dupC, has been identified in exon 8 of 12 of the CLCN5 gene. This duplication is predicted to create a frameshift starting at amino acid position 374, introducing a stop codon two residues downstream (NP_000075.1(CLCN5):p. (Asn374Glnfs*2)). This variant is predicted to result in loss of protein function through nonsense mediated decay, which is a reported mechanism of pathogenicity for this gene. The variant is absent in population databases (gnomAD, dbSNP, 1000G) and has not been previously reported in clinical cases. However, many other upstream and downstream loss of function variants have been reported pathogenic (ClinVar). Based on the information available at the time of curation, this variant has been classified as PATHOGENIC.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Whole Exome Sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Hematuria</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000790" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Proteinuria</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0000093" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Medullary nephrocalcinosis</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0012408" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLCN5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000084.4:c.1119dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300009" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8068330</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2819607" TraitType="Finding" MappingType="Name" MappingValue="Hematuria" MappingRef="Preferred">
        <MedGen CUI="C0018965" Name="Hematuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2819607" TraitType="Finding" MappingType="Name" MappingValue="Medullary nephrocalcinosis" MappingRef="Preferred">
        <MedGen CUI="C0403477" Name="Medullary nephrocalcinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2819607" TraitType="Finding" MappingType="Name" MappingValue="Proteinuria" MappingRef="Preferred">
        <MedGen CUI="C0033687" Name="Proteinuria" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2819607" TraitType="Disease" MappingType="XRef" MappingValue="300009" MappingRef="OMIM">
        <MedGen CUI="C1848336" Name="Dent disease type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

